Synprosis - Peptide, Protein and Synthetic Vaccine Developments

Synprosis is a French company specialized in synthetic vaccine developments, long peptide and protein developments and drug delivery systems for vaccines. Synprosis is specialized in solid phase manufacture of peptides and synthetic small proteins for basic research and for therapeutic applications (cGMP)

Thanks to our proprietary technologies, we synthesize small proteins. A 100 AA peptide would take longer than four to five weeks.

SYNTHETIC VACCINE DEVELOPMENTS

Synprosis can manage your vaccine project. Our range of services includes manufacturing of your peptides or your small proteins for preclinical and clinical phases (cGMP), regulatory document developments, formulation studies, excipient efficiency studies and preclinical studies management.

PEPTIDE AND PROTEIN DEVELOPMENTS

We are specializing in the manufacture of peptides and small proteins (120 AA) for basic research and for therapeutic applications. All of our peptides are synthesized in solid phase manufacture.

These peptides or proteins can be use for basic research or for therapeutic applications. Our services include the manufacturing of your peptides under cGMP in compliance with ICH guideline and all the regulatory support you need. We can provide you comprehensive regulatory support, included all batch documentation and support documentation your require for your regulatory filling.

DRUG DELIVERY SYSTEMS FOR VACCINES

Thanks to these proprietary technologies, we can develop novels drug delivery for vaccine. All of ours drug delivery systems are totally synthetics. They can be use with DNA vaccines or current vaccines

SYNPROSIS - SYNTHETIC SMALL PROTEINS MANUFACTURER AND VACCINES BUILDER

Synprosis' services include:

• Small scale, non-Gmp development for peptides and proteins
• Preclinical development and production
• cGMP production for clinical trials
• Regulatory documentations for injectable form development (preclinical and clinical trial)
• Vaccine formulation studies
• Vaccine's excipient efficiency studies
• Vaccine preclinical studies management
• Drug delivery systems for vaccines